ArticleJournal of fungi (Basel, Switzerland)2026
E3 Ubiquitin Ligase Rsp5 Controls Lifestyle Transition and Pathogenicity in
Article in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Fungi have evolved sophisticated mechanisms to survive in complex environments. Nematode-trapping fungi (NTF) sense and recognize nematode prey to transition from a saprophytic to predatory lifestyle, rendering them promising biocontrol agents against plant-parasitic nematodes. Ubiquitination is essential for eukaryotic cellular homeostasis, yet its regulation of NTF development and pathogenicity remains unclear. Here, we identify the conserved E3 ubiquitin ligase AoRsp5 as a critical factor for all major life stages of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.